Ann: Cellmid raises $4M to leverage sales growth, page-108

Hi there Maldowl.  

That 2010 trader manipulated pump and dump run was many years ago now.  The pump took about a day and a half with the following dump happening over a week or so.  Events like that are best avoided IMHO.

By contrast the latest rise has taken over a month to get where it is and is based on revenue guidance, board and scientific credentials, MK antibody performance, solidifying partnerships and a near term expectation of launching OTC products into the US and extended Asian markets.  On near term expected news I expect the SP  to go higher ..... but I'm quite happy to wait for that news to arrive and for the SP to be secured  fundumentals.

As posted there is plenty of money still at the sidelines.  Not everyone wants to be a early stage or emerging revenue earner investor.  Every investor is different.  Some may  be attracted by the mere fact of the company having the  necessary cast to get on with the job..... as is now the case

cheers